Share ownership Otsuka Holdings Co., Ltd.

4578

JP3188220002

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 06:30:00 06/02/2026 GMT			5-day change	1st Jan Change
9,344.00 ^JPY	-1.46%		+1.11%	+5.31%

02-04	Biodexa announces exclusive license of Otsuka's OPB-171775, a potent phase 1 ready molecular glue for GIST	RE
02-04	HBM Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2025	CI

Share class: Otsuka Holdings Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	552,024,717	448,359,624 ( 81.22 %)	14,932,021 ( 2.705 %)	81.22 %

Major shareholders: Otsuka Holdings Co., Ltd.

Name	Equities	%	Valuation
Otsuka Family 9.702 %	52,679,000	9.702 %	2 990 M ¥
Nomura Asset Management Co., Ltd. 4.821 %	26,177,500	4.821 %	1 486 M ¥
OTSUKA HOLDINGS CO., LTD. 2.736 %	14,857,500	2.736 %	843 M ¥
Otsuka Holdings Employee Stock Ownership Plan 2.318 %	12,584,000	2.318 %	714 M ¥
Amova Asset Management Co., Ltd. 2.256 %	12,251,700	2.256 %	695 M ¥
THE AWA BANK, LTD. 2.02 %	10,970,000	2.02 %	623 M ¥
RESONA HOLDINGS, INC. 1.025 %	5,568,000	1.025 %	316 M ¥
MEDIPAL HOLDINGS CORPORATION 0.979 %	5,316,000	0.979 %	302 M ¥
SUZUKEN CO., LTD. 0.6063 %	3,292,000	0.6063 %	187 M ¥
ALFRESA HOLDINGS CORPORATION 0.6026 %	3,272,000	0.6026 %	186 M ¥
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Aristotle Capital Management LLC 0.3011 %	3,269,516	0.3011 %	93 M ¥
Hantz Financial Services, Inc. 0.003888 %	42,223	0.003888 %	1 M ¥
State Street Global Advisors Europe Ltd. 0.003554 %	38,599	0.003554 %	1 M ¥
RhumbLine Advisers LP 0.001765 %	19,164	0.001765 %	542 418 ¥
GAMMA Investing LLC 0.000748 %	8,122	0.000748 %	229 885 ¥
Westside Investment Management LLC 0.000131 %	1,418	0.000131 %	40 135 ¥
Accent Capital Management LLC 0.000029 %	320	0.000029 %	9 057 ¥
Salomon & Ludwin LLC 0.000027 %	298	0.000027 %	8 435 ¥
Kerr Financial Planning Corp. 0.000009 %	100	0.000009 %	2 830 ¥
PNC Wealth Management LLC 0.000007 %	72	0.000007 %	2 038 ¥

Breakdown by shareholder type

Individuals	9.7%
Institutional	8.91%
Otsuka Holdings Co., Ltd.	2.74%
Other	2.36%
The Awa Bank Ltd.	2.02%
Resona Holdings, Inc.	1.03%
Medipal Holdings Corp.	0.98%
Suzuken Co., Ltd.	0.61%
Alfresa Holdings Corp.	0.6%
Vital KSK Holdings, Inc.	0.5%
Toho Holdings Co., Ltd.	0.37%
Toyo Seikan Group Holdings Ltd.	0.18%
MEGMILK SNOW BRAND Co., Ltd.	0.18%
Ohki Health Care Holdings Co., Ltd.	0.15%
TBS Holdings, Inc.	0.12%
MatsukiyoCocokara & Co.	0.09%
Ono Pharmaceutical Co., Ltd.	0.09%
Sompo Holdings, Inc.	0.07%
Nomura Holdings, Inc.	0.06%
Shochiku Co., Ltd.	0.04%
Kurita Water Industries Ltd.	0.04%
Bridgestone Corp.	0.04%
HOKUYAKU TAKEYAMA Holdings, Inc.	0.03%
Carlit Co., Ltd.	0.01%
Unknown	69.08%

Based on 1000 largest holdings

Geographical origin of shareholders

Japan	19.55%
Individuals	9.7%
United States	0.96%
United Kingdom	0.16%
Sweden	0.12%
Norway	0.09%
Ireland	0.09%
Spain	0.05%
Austria	0.03%
Switzerland	0.02%
Finland	0.02%
Luxembourg	0.02%
Singapore	0.01%
Denmark	0.01%
Italy	0.01%
Canada	0.01%
France	0.01%
Belgium	0.01%
New Zealand	0.01%
Australia	0.01%
Netherlands	0.01%

Based on 1000 largest holdings

Otsuka Holdings Co Ltd is a Japan-based company mainly engaged in medical, nutraceutical, consumer and other business activities in Japan and overseas. The Company operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.

Employees

35,338

Sector

Pharmaceuticals

Calendar

02-12 - Q4 2025 Earnings Release

More about the company